Research and development talks
Here, we share our views on key topics in research and development (R&D) such as the importance of science driven by unmet patient needs, fostering innovation through scientific collaborations, the need to attract the best minds, while leveraging our unique set of protein competencies in order to bring new treatments to people living with chronic diseases.
Our history
Mads Krogsgaard Thomsen, Executive Vice President and Chief Science Officer of Novo Nordisk, tells about Hvidøre, formerly founded by Novo Nordisk as one of the world's first diabetes hospitals. Hvidøre Hospital represents our heritage as a company that works closely with patients and healthcare professionals to continuously advance the treatment of diabetes.
Diabetes: An increasing disease burden with great unmet needs
Alan Moses, Global Chief Medical Officer at Novo Nordisk, explains why diabetes continues to be poorly controlled despite significant treatment advances.
